NEO

China has approved NEO, the world's first invasive brain-computer interface (BCI) device developed by Neuracle Technology, for clinical use in treating spinal cord injury patients with limb paralysis, marking a major step toward real-world BCI applications.

China has approved the world’s first invasive brain-computer interface chip, NEO, for clinical use, marking a major leap in neural technology leadership.

To achieve income growth, prioritize active income accumulation over passive income until reaching a $1M asset base, then focus on skill development to adapt to AI-driven changes.

The article introduces an AI agent called NEO that can build AI models, agents, and applications from a single prompt.